Human Energy ExpenditureNCT01938794
A New Approach to Measuring Energy Expenditure in Humans
An observational study of Human Energy Expenditure, run by University of Colorado, Denver at 1 site in United States.
Trial summary
Accurately measuring how many calories a person burns each day is difficult to do. Researchers can do this with a technique called doubly labeled water (DLW). This involves drinking water that is "labeled" with a non-radioactive tracer. After a few hours, the labeled water can be detected in the urine. Read more about this study
- Who is it for?
- Ages 18 to 99 yearsHealthy volunteers can take part
- Conditions the study is for
- Human Energy Expenditure
- How many people
- 72 participants
- Where
- 1 siteUnited States
- Study dates
- Sep 2013to 31 Dec 2017
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 99 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Healthy adults (>18 yrs)
Who may be able to join
- Age > 18yrs
Who cannot join
- Smokers
- weight > 300 lbs
- chronic disease (e.g. diabetes, heart disease, thyroid disease)
Trial locations and contacts
1 site in 1 country.
United States1 site
University of Colorado Anschutz Medical Campus
Aurora, Colorado, 80045
About this study
Official title: Improvements to the Doubly Labeled Water Technique to Measure Total Daily Energy Expenditure
Accurately measuring how many calories a person burns each day is difficult to do. Researchers can do this with a technique called doubly labeled water (DLW). This involves drinking water that is "labeled" with a non-radioactive tracer. After a few hours, the labeled water can be detected in the urine. To measure how many calories are burned (Total daily energy expenditure, TDEE), urine samples are collected several days apart. Although this technique is accurate, it is also challenging for two reasons. First, the labeled water is expensive. Second, the urine samples are analyzed using equipment (Isotope Ratio Mass Spectrometer, or IRMS) that is expensive and difficult to operate. The goal of this project is to develop a new instrument to perform DLW measurements of TDEE. This instrument, called a triple isotope water analyzer (TIWA) is less expensive and easier to operate than IRMS. Additionally, since the TIWA is more accurate than IRMS, it may potentially reduce the amount of labeled water required to measure TDEE, and thus reduce costs. The purpose of this study is to compare the accuracy of measuring TDEE from labeled water using the new instrument (TIWA) and from the traditional approach (IRMS). We will also compare the accuracy to the measurement of TDEE from whole-room indirect calorimetry (metabolic room), which is considered the most accurate way to measure TDEE.
Read the detailed description
The high prevalence of obesity in the US (17) is a major public health concern, as overweight and obese individuals are at increased risk for many chronic diseases (5, 7, 15, 18). Obesity stems from an imbalance between total caloric consumption and total energy expenditure (TEE), although the causes of this imbalance remain debated (29). Accurate and precise measurements of TEE therefore play a pivotal role in understanding and ultimately reversing this epidemic. TEE can be measured using direct (measurement of heat production) or indirect (measurement of respiratory gas exchange) calorimetry (4), but neither of these approaches are practical for measuring TEE in free living subjects. The gold standard for measuring TEE in free-living individuals is the doubly labeled water (DLW) method, which is based on the principle that the oxygen in body water is in complete isotopic equilibrium with the oxygen in dissolved respiratory carbon dioxide due to the action of carbonic anhydrase. The consequence of this exchange is that an isotopic label of oxygen introduced into body water is eliminated by the combined flux of body water and the exhaled carbon dioxide. Lifson and colleagues reasoned that, since hydrogen is found only in water and not in carbon dioxide, the elimination of a hydrogen isotope would be affected solely by the flux of body water (11). Thus the difference in the rates of isotope elimination of simultaneously administered oxygen and hydrogen labels is a measure of CO2 production.
However, despite its widespread use (6, 9, 10, 20, 25, 29), the DLW method has some major limitations. Individual measurements are only precise to ± 7 % at best (23), so the method is currently most suitable for studies of groups rather than individual variation. A second problem is that the test is expensive to perform due to the need for relatively large sample sizes to achieve sufficient statistical power, the large quantities of H218O needed for dosing (23), and IRMS analysis. High levels of 18O are required to distinguish the dose from background isotope levels after 10 - 21 days of elimination. It currently costs $500 - $750 for the 18O required to perform a DLW measurement on an adult subject (50 - 75 kg fat free mass) and the cost is unpredictable due to fluctuations in demand from the medical diagnostic PET scan. The need for high 18O enrichments is caused by fluctuations in the background isotope levels over time (8). This uncertainty in the background levels increases the isotope dose that must be administered and contributes to the uncertainty in the DLW measurements as compared to the reference calorimetry measurements of TEE in validation studies. Finally, IRMS analysis presents its own set of challenges, including the need for sophisticated, expensive instrumentation with dedicated, highly trained operators, and, in general, measurement of only one isotope ratio at a time, reducing analytical throughput. Because of these challenges, most researchers conducting DLW tests do not maintain in-house IRMS facilities, relying instead on expensive and slow analyses by outside measurement laboratories. The proposed work will address these problems by developing a new triple-isotope method for DLW analysis, significantly improving the individual accuracy of the measurements and reducing the cost of the DLW method, leading to more widespread use of the DLW method in both clinical and research applications.
The overall goal of this Small Business Innovation Research (SBIR) Phase II grant is to develop and validate a new instrument to measure and correct for the background isotope levels of 18O and 2H during DLW analysis by measuring the 17O stable isotope of oxygen in body water. This approach will address the two major limitations addressed above. First, by using 17O measurements to correct for background fluctuations in 18O and 2H, this approach will reduce the amount of 18O, and thus cost, of performing DLW studies. Results from our Phase I studies (see Preliminary Data below) show that background fluctuations in 18O and 17O in body water are correlated with an R2 of 0.96, background fluctuations in 2H and 17O are correlated with an R2 of 0.89, and background fluctuations in 2H and 18O are correlated with an R2 of 0.92. Based on these correlations, using 17O measurements to estimate the background fluctuations of the 2H and 18O will provide an estimated forty percent decrease in the uncertainty of the DLW method due to background fluctuation. Second, The proposed instrument will be utilized in the new, triple-isotope method for DLW which will reduce existing barriers to widespread use of the DLW method by improving precision, reducing costs, reducing the technical expertise required to perform the analysis, and increasing throughput. Development of the new instrument will be performed by our business partners, Los Gatos Research, and validation studies will be performed at the University of Colorado Anschutz Medical campus.
In this work, we will apply Los Gatos Research's ultrasensitive absorption spectroscopy technology, Off-Axis Integrated Cavity Output Spectroscopy (Off-Axis ICOS), to simultaneously and inexpensively (< $50 per sample) measure 2H, 18O, and 17O in liquid water samples. Briefly, in Off-Axis ICOS, laser light is coupled to an optical cavity in an off-axis fashion and is continuously measured similar to a standard absorption experiment (Figure 1) (1). The cavity provides an extraordinarily long effective optical pathlength (e.g. typically 5 - 10 km) allowing for the accurate quantification of weakly absorbing molecules. Moreover, since the off-axis beam path is not unique, the system is extremely insensitive to changes in alignment, making it robust. This robustness combined with the long effective optical pathlength makes it possible to measure water isotopomers with very high precision. Since its development, Los Gatos Research (LGR) and its commercial customers have performed many experiments to validate the sensitivity and robustness of Off-Axis ICOS to measure a variety of trace gases including water isotopomers H2O, 1H2HO, and H218O (2, 12, 14, 19, 26, 27) and most recently water isotopomers in undistilled human urine (3).
- Conditions
- Human Energy Expenditure
What is being measured
The primary outcome is the main question the study is designed to answer.
Daily energy expenditure
Measured: 7 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted10 Sep 2013 (estimated)
- Study startSep 2013
- Primary completion31 Aug 2017
- Study completion31 Dec 2017
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Human Energy ExpenditureStudies of the same condition, open and under way.
- More trials run by University of Colorado, DenverThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 72 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Colorado, Denver
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Edward L Melanson, PhD, Principal investigator, University of Colorado, Denver
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01938794
- Sponsor's protocol ID
- 13-1497
- Other IDs
- R44DK093362
- Status last verified
- Oct 2019
- First submitted
- 5 Sep 2013
- Last updated
- 9 Oct 2019
- Results posted
- No
- Data monitoring committee
- No
Publications
Melanson EL, Swibas T, Kohrt WM, Catenacci VA, Creasy SA, Plasqui G, Wouters L, Speakman JR, Berman ESF. Validation of the doubly labeled water method using off-axis integrated cavity output spectroscopy and isotope ratio mass spectrometry. Am J Physiol Endocrinol Metab. 2018 Feb 1;314(2):E124-E130. doi: 10.1152/ajpendo.00241.2017. Epub 2017 Oct 3.
PubMed 28978547
Study at a glance
From the registry record, last updated by the sponsor on 9 Oct 2019. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Improvements to the Doubly Labeled Water Technique to Measure Total Daily Energy Expenditure
- ClinicalTrials.gov ID
- NCT01938794
- Acronym / sponsor ID
- 13-1497
- Conditions
- Human Energy Expenditure
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 72 participants (actual)
- Lead sponsor
- University of Colorado, DenverUniversity, hospital or other
- Collaborators
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Study start
- Sep 2013
- Primary completion
- 31 Aug 2017 (actual)
- Study completion
- 31 Dec 2017 (actual)
- First posted
- 10 Sep 2013 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Accurately measuring how many calories a person burns each day is difficult to do. Researchers can do this with a technique called doubly labeled water (DLW). This involves drinking water that is "labeled" with a non-radioactive tracer. After a few hours, the labeled water can be detected in the urine. To measure how many calories are burned (Total daily energy expenditure, TDEE), urine samples are collected several days apart. Although this technique is accurate, it is also challenging for two reasons. First, the labeled water is expensive. Second, the urine samples are analyzed using equipment (Isotope Ratio Mass Spectrometer, or IRMS) that is expensive and difficult to operate. The goal of this project is to develop a new instrument to perform DLW measurements of TDEE. This instrument, called a triple isotope water analyzer (TIWA) is less expensive and easier to operate than IRMS. Additionally, since the TIWA is more accurate than IRMS, it may potentially reduce the amount of labeled water required to measure TDEE, and thus reduce costs. The purpose of this study is to compare the accuracy of measuring TDEE from labeled water using the new instrument (TIWA) and from the traditional approach (IRMS). We will also compare the accuracy to the measurement of TDEE from whole-room indirect calorimetry (metabolic room), which is considered the most accurate way to measure TDEE.
Detailed description
The high prevalence of obesity in the US (17) is a major public health concern, as overweight and obese individuals are at increased risk for many chronic diseases (5, 7, 15, 18). Obesity stems from an imbalance between total caloric consumption and total energy expenditure (TEE), although the causes of this imbalance remain debated (29). Accurate and precise measurements of TEE therefore play a pivotal role in understanding and ultimately reversing this epidemic. TEE can be measured using direct (measurement of heat production) or indirect (measurement of respiratory gas exchange) calorimetry (4), but neither of these approaches are practical for measuring TEE in free living subjects. The gold standard for measuring TEE in free-living individuals is the doubly labeled water (DLW) method, which is based on the principle that the oxygen in body water is in complete isotopic equilibrium with the oxygen in dissolved respiratory carbon dioxide due to the action of carbonic anhydrase. The consequence of this exchange is that an isotopic label of oxygen introduced into body water is eliminated by the combined flux of body water and the exhaled carbon dioxide. Lifson and colleagues reasoned that, since hydrogen is found only in water and not in carbon dioxide, the elimination of a hydrogen isotope would be affected solely by the flux of body water (11). Thus the difference in the rates of isotope elimination of simultaneously administered oxygen and hydrogen labels is a measure of CO2 production.
However, despite its widespread use (6, 9, 10, 20, 25, 29), the DLW method has some major limitations. Individual measurements are only precise to ± 7 % at best (23), so the method is currently most suitable for studies of groups rather than individual variation. A second problem is that the test is expensive to perform due to the need for relatively large sample sizes to achieve sufficient statistical power, the large quantities of H218O needed for dosing (23), and IRMS analysis. High levels of 18O are required to distinguish the dose from background isotope levels after 10 - 21 days of elimination. It currently costs $500 - $750 for the 18O required to perform a DLW measurement on an adult subject (50 - 75 kg fat free mass) and the cost is unpredictable due to fluctuations in demand from the medical diagnostic PET scan. The need for high 18O enrichments is caused by fluctuations in the background isotope levels over time (8). This uncertainty in the background levels increases the isotope dose that must be administered and contributes to the uncertainty in the DLW measurements as compared to the reference calorimetry measurements of TEE in validation studies. Finally, IRMS analysis presents its own set of challenges, including the need for sophisticated, expensive instrumentation with dedicated, highly trained operators, and, in general, measurement of only one isotope ratio at a time, reducing analytical throughput. Because of these challenges, most researchers conducting DLW tests do not maintain in-house IRMS facilities, relying instead on expensive and slow analyses by outside measurement laboratories. The proposed work will address these problems by developing a new triple-isotope method for DLW analysis, significantly improving the individual accuracy of the measurements and reducing the cost of the DLW method, leading to more widespread use of the DLW method in both clinical and research applications.
The overall goal of this Small Business Innovation Research (SBIR) Phase II grant is to develop and validate a new instrument to measure and correct for the background isotope levels of 18O and 2H during DLW analysis by measuring the 17O stable isotope of oxygen in body water. This approach will address the two major limitations addressed above. First, by using 17O measurements to correct for background fluctuations in 18O and 2H, this approach will reduce the amount of 18O, and thus cost, of performing DLW studies. Results from our Phase I studies (see Preliminary Data below) show that background fluctuations in 18O and 17O in body water are correlated with an R2 of 0.96, background fluctuations in 2H and 17O are correlated with an R2 of 0.89, and background fluctuations in 2H and 18O are correlated with an R2 of 0.92. Based on these correlations, using 17O measurements to estimate the background fluctuations of the 2H and 18O will provide an estimated forty percent decrease in the uncertainty of the DLW method due to background fluctuation. Second, The proposed instrument will be utilized in the new, triple-isotope method for DLW which will reduce existing barriers to widespread use of the DLW method by improving precision, reducing costs, reducing the technical expertise required to perform the analysis, and increasing throughput. Development of the new instrument will be performed by our business partners, Los Gatos Research, and validation studies will be performed at the University of Colorado Anschutz Medical campus.
In this work, we will apply Los Gatos Research's ultrasensitive absorption spectroscopy technology, Off-Axis Integrated Cavity Output Spectroscopy (Off-Axis ICOS), to simultaneously and inexpensively (< $50 per sample) measure 2H, 18O, and 17O in liquid water samples. Briefly, in Off-Axis ICOS, laser light is coupled to an optical cavity in an off-axis fashion and is continuously measured similar to a standard absorption experiment (Figure 1) (1). The cavity provides an extraordinarily long effective optical pathlength (e.g. typically 5 - 10 km) allowing for the accurate quantification of weakly absorbing molecules. Moreover, since the off-axis beam path is not unique, the system is extremely insensitive to changes in alignment, making it robust. This robustness combined with the long effective optical pathlength makes it possible to measure water isotopomers with very high precision. Since its development, Los Gatos Research (LGR) and its commercial customers have performed many experiments to validate the sensitivity and robustness of Off-Axis ICOS to measure a variety of trace gases including water isotopomers H2O, 1H2HO, and H218O (2, 12, 14, 19, 26, 27) and most recently water isotopomers in undistilled human urine (3).
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 18 to 99 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Healthy adults (>18 yrs)
Key inclusion criteria (1 listed)
- Age > 18yrs
Key exclusion criteria (3 listed)
- Smokers
- weight > 300 lbs
- chronic disease (e.g. diabetes, heart disease, thyroid disease)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Daily energy expenditure
Time frame: 7 days
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Oct 2019.
- Derived from this study: PubMed 28978547Melanson EL, Swibas T, Kohrt WM, Catenacci VA, Creasy SA, Plasqui G, Wouters L, Speakman JR, Berman ESF. Validation of the doubly labeled water method using off-axis integrated cavity output spectroscopy and isotope ratio mass spectrometry. Am J Physiol Endocrinol Metab. 2018 Feb 1;314(2):E124-E130. doi: 10.1152/ajpendo.00241.2017. Epub 2017 Oct 3.
Related trials for Human Energy Expenditure
Recruiting
GENESIS: Genotype Guided - Natriuretic Peptides - Cardiometabolic Health Study
Cardiovascular Diseases, Natriuretic Peptides
Recruiting
Stress and Menstrual Health
Menstrual Dysfunction
Active, not recruitingObservational study
Intestinal Metabolic Reprogramming as a Key Mechanism of Gastric Bypass in Humans
Obesity, Diabetes Mellitus, Type 2
RecruitingObservational study
Hormonal And Metabolic Signatures In Human Hypothalamic Neurons In Anorexia Nervosa
Anorexia Nervosa
Active, not recruiting
Adaptation of Human Brown Adipose Tissue to Calorie Restriction
Obesity and Overweight
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Edward L Melanson, PhD principal investigator
University of Colorado, Denver
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Human Energy Expenditure, run by University of Colorado, Denver at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 9 Oct 2019. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Daily energy expenditure (time frame: 7 days). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01938794, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Oct 2019.